stars 1 stars 2 stars 3

Nano Daru is a generic manufacturer with the focus on high-technology medications and novel drug delivery systems. We are known among leading nano-tech companies in Iran and our owned production lines are unique. They are designed to produce high-tech microspheres, nano particles, and antibody-drug conjugates. Also, our conventional products are manufactured in hazard and non-hazard production lines. Delivering hope to the global community and patients all over the world is what we are here for. We try to make a difference in patients’ lives by providing access to innovative but affordable, quality medicines. Our experts from different backgrounds have gathered to serve patients by exploring quality, high technology anticancer medications, orphan drugs, and novel drug delivery systems. Evolving year on year and always eager to work with like-minded collaborators has enabled us growing continuously with a promising pipeline. We owe a huge thanks to our community and investors for joining us on this awesome journey, and we hope that they will continue to be a part of our story.

NanoDaru Questions

The NanoDaru annual revenue was $3 million in 2026.

Navid Nateghian is the Vice President of NanoDaru.

65 people are employed at NanoDaru.

The NAICS codes for NanoDaru are [32541, 325, 32, 3254].

The SIC codes for NanoDaru are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users